ArticleActa pharmacologica Sinica2026
Targeting JOSD2 degrades β-catenin to suppress colorectal cancer metastasis by disrupting RAS/ERK/β-catenin axis.
Yue Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleActa pharmacologica Sinica2026
Yue Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.